PlainRecalls
FDA Drug Moderate Class II Terminated

INFeD (Iron Dextran Injection USP) 100 mg elemental iron/2 ml (50 mg/mL), Rx Only, packaged in a) single dose vials, (NDC 52544-931-07), b) carton of 10 x 2 ml Single Dose Vials (NDC 52544-931-02) Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054, Manufactured by: Patheon Italia S.p.A. Ferentino, Italy 03013.

Reported: March 7, 2018 Initiated: December 13, 2017 #D-0545-2018

Product Description

INFeD (Iron Dextran Injection USP) 100 mg elemental iron/2 ml (50 mg/mL), Rx Only, packaged in a) single dose vials, (NDC 52544-931-07), b) carton of 10 x 2 ml Single Dose Vials (NDC 52544-931-02) Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054, Manufactured by: Patheon Italia S.p.A. Ferentino, Italy 03013.

Reason for Recall

Failed Stability Specifications: Product stability testing results did not meet specifications for iron content.

Details

Recalling Firm
ALLERGAN
Units Affected
163,694 cartons
Distribution
Product was distributed nationwide in the USA.
Location
Madison, NJ

Frequently Asked Questions

What product was recalled?
INFeD (Iron Dextran Injection USP) 100 mg elemental iron/2 ml (50 mg/mL), Rx Only, packaged in a) single dose vials, (NDC 52544-931-07), b) carton of 10 x 2 ml Single Dose Vials (NDC 52544-931-02) Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054, Manufactured by: Patheon Italia S.p.A. Ferentino, Italy 03013.. Recalled by ALLERGAN. Units affected: 163,694 cartons.
Why was this product recalled?
Failed Stability Specifications: Product stability testing results did not meet specifications for iron content.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 7, 2018. Severity: Moderate. Recall number: D-0545-2018.